[Pharmacologic therapy for patients with stable chronic obstructive pulmonary disease--emphasis on inhaled agents]

Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Dec:34 Suppl:75-8.
[Article in Japanese]

Abstract

One dose of an anticholinergic agents has about the same bronchodilatory effect as one of a beta 2-agonist. Anticholinergic agents may be used first in patients with stable chronic obstructive pulmonary disease, because of the possible adverse effects of beta 2-agonists. One puff of a metered-dose inhaler will not cause a maximal bronchodilatory effect. Both anticholinergic and beta-adrenergic drugs cause dose-dependent bronchodilation when given as aerosols from metered-dose inhalers, and a combination of the two can provide better results. If the response to a single agent is unsatisfactory, use of higher doses is advised and the use of a combination of anticholinergic agents and beta-agonists is recommended. With regard to inhaled corticosteroids, a high dose of inhaled beclomethasone dipropionate (1,500 micrograms per day) can be a effective as oral corticosteroids. Step-by-step pharmacologic therapy with the drugs mentioned above should be used in outpatient management of patients with chronic obstructive pulmonary disease.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Administration, Inhalation
  • Adrenergic beta-Agonists / administration & dosage*
  • Anti-Inflammatory Agents / administration & dosage*
  • Cholinergic Antagonists / administration & dosage*
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Humans
  • Lung Diseases, Obstructive / drug therapy*
  • Quality of Life
  • Steroids

Substances

  • Adrenergic beta-Agonists
  • Anti-Inflammatory Agents
  • Cholinergic Antagonists
  • Steroids